文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

在 cN0 乳腺癌中,失败的前哨淋巴结定位是否预示着转移?

Does failed mapping predict sentinel lymph node metastasis in cN0 breast cancer?

机构信息

Breast Cancer Surgery Division, European Institute of Oncology, IRCCS, Milan, 20141, Italy.

Departmentof Oncology & Hemato-Oncology, University of Milan, Milan, 20122, Italy.

出版信息

Future Oncol. 2022 Jan;18(2):193-204. doi: 10.2217/fon-2021-0470. Epub 2021 Dec 9.


DOI:10.2217/fon-2021-0470
PMID:34882010
Abstract

The clinical significance of nonvisualized sentinel lymph nodes (non-vSLNs) is unknown. The authors sought to determine the incidence of non-vSLNs on lymphoscintigraphy, the identification rate during surgery, factors associated with non-vSLNs and related axillary management.  A total of 30,508 consecutive SLN procedures performed at a single institution from 2000 to 2017 were retrospectively studied. Associations between clinicopathological factors and the identification of SLNs during surgery were assessed. Non-vSLN occurred in 525 of the procedures (1.7%). In 73.3%, at least one SLN was identified intraoperatively. Nodal involvement was only significantly associated with SLN nonidentification (p < 0.001). Patients with non-vSLN had an increased risk for SLN metastasis. The detection rate during surgery was consistent, reducing the amount of unnecessary axillary dissection.

摘要

前哨淋巴结(SLN)未显影的临床意义尚不清楚。作者旨在确定淋巴闪烁显像术上未显影 SLN(non-vSLNs)的发生率、术中识别率、与 non-vSLNs 相关的因素及相关的腋窝管理。本研究回顾性分析了 2000 年至 2017 年在一家机构连续进行的 30508 例 SLN 手术。评估了临床病理因素与术中 SLN 识别之间的相关性。在 525 例手术中(1.7%)出现了 non-vSLN。73.3%的手术中至少识别到一个 SLN。淋巴结受累与 SLN 无法识别显著相关(p < 0.001)。non-vSLN 患者发生 SLN 转移的风险增加。术中检测率一致,减少了不必要的腋窝清扫。

相似文献

[1]
Does failed mapping predict sentinel lymph node metastasis in cN0 breast cancer?

Future Oncol. 2022-1

[2]
Clinical risk analysis of non-visualized sentinel lymph node in breast cancer.

Cancer Biomark. 2018

[3]
Non-visualized sentinel nodes in breast cancer patients; prevalence, risk factors, and prognosis.

Breast Cancer Res Treat. 2017-8-31

[4]
Management of sentinel node re-mapping in patients who have second or recurrent breast cancer and had previous axillary procedures.

World J Surg Oncol. 2014-7-12

[5]
Predicting Nonsentinel Lymph Node Metastasis in Breast Cancer: A Multicenter Retrospective Study.

J Surg Res. 2021-8

[6]
Prediction of non-sentinel lymph node metastases in T1-2 sentinel lymph node-positive breast cancer patients undergoing mastectomy following neoadjuvant therapy.

World J Surg Oncol. 2024-9-28

[7]
Dye- and gamma probe-guided sentinel lymph node biopsy in breast cancer patients: using patent blue dye and technetium-99m-labeled human serum albumin.

Breast Cancer. 2000-1

[8]
Additional Nodal Disease Prediction in Breast Cancer with Sentinel Lymph Node Metastasis Based on Clinicopathological Features.

Anticancer Res. 2018-4

[9]
Locoregional Management of the Axilla in Mastectomy Patients with One or Two Positive Sentinel Nodes: The Role of Intraoperative Pathology.

Clin Breast Cancer. 2021-10

[10]
Role of number of sentinel nodes in predicting non-sentinel node metastasis in breast cancer.

J Int Med Res. 2018-2

引用本文的文献

[1]
The Impact of Lymphoscintigraphy Visualization on the Prognosis of Early Breast Cancer Patients Undergoing Sentinel Node Biopsy: A 20-year, Single-center Experience.

Cancer Diagn Progn. 2025-6-30

[2]
Update on Sentinel Lymph Node Methods and Pathology in Breast Cancer.

Diagnostics (Basel). 2024-1-24

[3]
Future Directions in the Assessment of Axillary Lymph Nodes in Patients with Breast Cancer.

Medicina (Kaunas). 2023-8-25

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索